课题基金 / 基金详情

MEETING ON MOLECULAR BASIS OF TUMOR IMMUNOLOGY

MEETING ON MOLECULAR BASIS OF TUMOR IMMUNOLOGY
肿瘤免疫学分子基础会议
批准号:
3434127
负责人:
ELLEN S VITETTA
金额:
$0.6万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-15 至 1991-04-14

项目摘要

项目成果

ELLEN S VITETTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Support is requested for a scientific meeting organized by the American Association for Cancer Research, Inc. (AACR). The conference is entitled "Molecular Basis of Tumor Immunology" and will be held at the Sheraton Reston Hotel in Reston, Virginia, on May 20-22, 1990. The Organizing Committee for this conference consists of Drs. Tak W. Mak, Chairperson; Lloyd J. Old; and Ellen S. Vitetta, Principal Investigator. Twenty scientific leaders in the fields of molecular biology, molecular immunology, and tumor immunology will make presentations aimed at producing not only a better understanding of the evolution of tumor development, but also the eventual control of growth malignant cells. Approximately 150 other participants will have the opportunity to present their own work during a poster session. It is anticipated that this exchange of ideas between molecular immunologists and oncologists will produce new approaches and experiments that will lead to the containment of neoplastic evolution through manipulation of the immune cells and their products. Recent studies of immunoglobulin genes, T-cell receptor genes, the processing of antigens, MHC genes, and T-lymphocytes have supported the hypothesis that the immune system and its genes may be involved in the regulation of neoplastic growth. Previous scientific meetings have concentrated on one or two of the scientific areas described above. Our proposal is to focus on all the molecular aspects of immune recognition pertaining to neoplastic genesis and growth. Participants will be drawn from all relevant scientific areas and all levels of training, from graduate students to senior scientists or physicians. The resulting exchange of information should produce valuable new leads for both the laboratory and the clinic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel vaccine to prevent HCV infection and hence liver cancer
  • 批准号:
    7943947
  • 项目类别:
  • 资助金额:
    $62.0万
  • 财政年份:
    2009
  • 负责人:
    ELLEN S VITETTA
  • 依托单位:
A novel vaccine to prevent HCV infection and hence liver cancer
  • 批准号:
    7852639
  • 项目类别:
  • 资助金额:
    $68.37万
  • 财政年份:
    2009
  • 负责人:
    ELLEN S VITETTA
  • 依托单位:
PHASE 1 STUDY OF SAFETY & IMMUNOGENICITY OF AN ALUM-FORMULATED RECOMBINANT RICIN
  • 批准号:
    7475286
  • 项目类别:
  • 资助金额:
    $32.17万
  • 财政年份:
    2007
  • 负责人:
    ELLEN S VITETTA
  • 依托单位:
PHASE 1 STUDY OF SAFETY & IMMUNOGENICITY OF AN ALUM-FORMULATED RECOMBINANT RICIN
  • 批准号:
    7213715
  • 项目类别:
  • 资助金额:
    $30.77万
  • 财政年份:
    2007
  • 负责人:
    ELLEN S VITETTA
  • 依托单位:
海外基金